Peptide record

TPDB92200

Ziconotide SNX-111 Antibacterial Antifungal Blood-Brain Barrier Toxicity modified_plain modified
25 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.

Standard-residue backbone model; source-recorded chemical modifications are not verified in these coordinates.

TPDB92200
Ziconotide SNX-111
Antibacterial Antifungal Blood-Brain Barrier Toxicity
Anti-infective peptides Toxicity and safety peptides Delivery and barrier-penetrating peptides
AntiBP3 Peptipedia CAFPdb dbAMP B3Pred BBPpredict pep-lab ToxinPred 3.0
modified_plain
Yes
A 25-aa modified multi-activity (Antibacterial, Antifungal, Blood-Brain Barrier, and other sources) peptide sequence curated from AntiBP3, Peptipedia, CAFPdb, and other sources, with an available 3D structural model.
Chemical: Cys1-Cys16 Chemical: Cys15-Cys25 Chemical: Cys8-Cys20
Sequence
CKGKGAKCSRLMYDCCTGSCRSGKC
Physicochemical Analysis

Sequence-only estimates are not provided for modified or non-standard source notation. Reported molecular properties, when available, are retained below with their source records.

Chemical Descriptors
25 reviewed residue count
Cys1-Cys16 Cys8-Cys20 Cys15-Cys25 Activity
Linear Activity
Cys-Lys-Gly-Lys-Gly-Ala-Lys-Cys-Ser-Arg-Leu-Met-Tyr-Asp-Cys-Cys-Thr-Gly-Ser-Cys-Arg-Ser-Gly-Lys-Cys Activity
C[C@H]1C(=O)N[C@H](C(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N1)CCCCN)CCCCN)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N3)CO)[C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC2=O)CO)CCCNC(=N)N)CC(C)C)CCSC)CC4=CC=C(C=C4)O)CC(=O)O)C(=O)N)CCCCN)CO)CCCNC(=N)N)CCCCN Activity
Evidence Records 4 records
Evidence 1 Activity

Activity

Blood-Brain Barrier
0.0042 mL/(g x min)

Assay & Model

Unidirectional flux rate constant

Source & Reference

NA
B3Pdb

Other

Chemically synthesized
in situ brain perfusion
Permeability
Direct iodination
Evidence 2 Activity

Activity

Blood-Brain Barrier
0.0018 ml/g

Assay & Model

Initial distribution vaolume

Source & Reference

NA
B3Pdb

Other

Chemically synthesized
in situ brain perfusion
Permeability
Direct iodination
Evidence 3 Activity

Activity

Blood-Brain Barrier
1.31%

Assay & Model

Capillary depletion
Rpellet

Source & Reference

NA
B3Pdb

Other

Chemically synthesized
Direct iodination
Evidence 4 Activity

Activity

Blood-Brain Barrier
5.58%

Assay & Model

Capillary depletion
Rsupernatant

Source & Reference

NA
B3Pdb

Other

Chemically synthesized
Direct iodination
Additional Detail Fields 1 fields
in situ brain perfusion